期刊文献+

西格列汀治疗2型糖尿病患者的疗效观察

下载PDF
导出
摘要 目的:观察西格列汀治疗2型糖尿病患者的疗效。方法:选取83例2型糖尿病患者按掷硬币法随机分为组1和组2。组1患者41例,采取2型糖尿病的常规疗法;组2患者42例,在组1基础上增加西格列汀治疗。比较两组患者的临床疗效。结果:组2患者控糖的总有效率95.24%(40/42),高于组1的75.61%(31/41),经x2检验组间数据差异有统计学意义(P<0.05);组2患者的低血糖和体重增加发生率较组1低,经x2检验组间数据差异有统计学意义(P<0.05);治疗前,两组患者的血糖指标,空腹血糖(FBG)和餐后2 h血糖(2 h PBG)、糖化血红蛋白相似;治疗后,组2患者的改善程度较组1更明显。结论:在常规疗法基础上,加用西格列汀治疗2型糖尿病患者的疗效优于单纯常规疗法。
作者 惠玉梅
出处 《中国民康医学》 2016年第20期29-30,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献7

二级参考文献121

  • 1王椿,喻红玲,梁荩忠,田浩明.糖尿病教育对2型糖尿病患者血糖控制的影响[J].中国循证医学杂志,2004,4(7):508-511. 被引量:17
  • 2潘长玉,金文胜.2型糖尿病流行病学[J].中华内分泌代谢杂志,2005,21(5). 被引量:168
  • 3何寒青,陈坤.Meta分析中的异质性检验方法[J].中国卫生统计,2006,23(6):486-487. 被引量:102
  • 4Hanefeld M, Herman GA, Wu M, et al. Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes[J]. Current Medical Research and Opinion,2007,23(6) : 1329 -1339.
  • 5Raz I, Hanefeld M, Xu L, el al. Efficacy and safety of the dipeptidyl peptidase 4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus[J]. Diabetologia, 2006, 49(11) : 2564 -2571.
  • 6Aschner P, Kipnes MS, Lunceford JK, et al. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes[J]. Diabetes Care, 2006, 29(12):2632 -2637.
  • 7Mohan V, Yang W, Son HY,etal. Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea. Diabetes Research and Clinical Practice [J ]. Diabetes Res Clin Pract, 2009,83 (l):106 -116.
  • 8Goldstein BJ, Feinglos MN, I.unceford JK, etal. Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycaemic control in patients with type 2 diabetes[J]. Diabetes Care, 2007,30(8) 1979- 1987.
  • 9Iwamoto Y, Tajima N, Kadowaki T, et al. Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial [J]. Diabetes Obes Metab,2010,12(?):613-622.
  • 10Tina Zerilli, Euniee Y. Pyon. Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus[J]. Clinical Therapeutics,2007,29(12) : 2614-2634.

共引文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部